Comprehensive Study Notes on Rift Valley Fever and Wesselsbron Disease

Overview and Definition of Rift Valley Fever

Rift Valley Fever (RVF) is an acute, arthropod-borne viral zoonotic disease that affects both animals and humans.

• Primary Impact on Livestock:

  • Causes severe abortion storms in pregnant ruminants (sheep, cattle, and goats).

  • Results in exceptionally high mortality rates among young animals, particularly lambs and kids.

• Impact on Humans:

  • Manifests as a generalized disease ranging from a severe influenza-like illness to life-threatening complications.

History and Geographical Distribution

Rift Valley Fever was historically recognized as a seasonal summer disease restricted to the African continent, but its range has expanded significantly.

• Historical Timeline and Spread:

  • 1931: First identified in Kenya, subsequently spreading throughout various regions of Africa.

  • 1976: Outbreaks documented in Sudan.

  • 1977: Spread to Egypt, causing major epidemics in 1977–1978 and again in 1993.

• African Distribution:

  • Endemic across most countries of sub-Saharan Africa.

  • Outbreaks documented in South Africa (1950–1951, 1974–1975), Zimbabwe (1955, 1957, 1969–1970, 1978), Namibia (1955, 1974–1976), Mozambique (1969), Zambia (1973–1974, 1978, 1985), Mauritania (1987, 1998), Madagascar (1990–1991), Somalia (1997–1998), and Tanzania (1997–1998).

• Intercontinental Expansion:

  • September 2000: Outbreaks recorded in Saudi Arabia and Yemen, marking the first confirmed occurrence of RVF outside the African continent.

  • Recent Developments: Human cases have been documented in China.

Etiology and Viral Characteristics

• Viral Classification:

  • Type: Arbovirus (Arthropod-borne virus) containing a single-stranded RNA genome.

  • Family: Bunyaviridae

  • Genus: Phlebovirus

• Hemagglutination Properties:

  • The virus possesses hemagglutinating (HA) properties capable of agglutinating goose red blood cells (RBCs).

Host Range and Relative Susceptibility

Rift Valley Fever primarily affects sheep, but it infects a wide range of domestic ruminants, wild vertebrates, and humans across all ages and sexes.

• General Susceptibility Profiles:

  • High Susceptibility: Young animals (lambs, calves, kids) and sheep.

  • Moderate Susceptibility: Adult cattle, buffaloes, goats, and humans.

  • Mild Susceptibility: Camels.

  • Camels (Specific to Egypt): Exhibit inapparent (subclinical) disease, with abortion being the sole clinical manifestation.

• Relative Susceptibility Scale:

  • Lambs: $++++$

  • Sheep and Calves: $+++$

  • Adult Cattle, Goats, and Sheep: $++$

  • Humans: $++$

  • Camels: $+$

Transmission Pathways and Vector Ecology

• Vector Transmission (Primary Route):

  • Transmitted primarily by biting female mosquitoes of the genera Aedes, Culex, and Anopheles, as well as other hematophagous insects such as Culicoides.

  • Biological Transmission: Mosquitoes serve as biological vectors with an extrinsic incubation period of $20\text{ to }29\text{ days}$.

  • Mechanical Transmission: Direct transfer via biting mouthparts of hematophagous flies.

  • Transovarial (Vertical) Transmission: Occurs in Aedes mosquitoes, where the virus is passed to eggs. These infected eggs resist desiccation during dry periods and hatch during heavy rainfall, triggering epizootics.

• Direct / Non-Vector Transmission Routes:

  • Aerosol Transmission: Inhalation of infectious viral aerosols, particularly during necropsy, slaughter, or laboratory handling of tissues.

  • Direct Contact / Wound Contamination: Infection through skin breaks or mucous membranes coming into contact with blood, bodily fluids, or aborted fetuses from infected animals.

Pathogenesis

• Pathogenesis of Fatal Systemic Infection:

  • Vector bite injects virus into susceptible host $\rightarrow$ Entry into blood stream $\rightarrow$ Viraemia accompanied by high fever (persisting for up to $7\text{ days}$) $\rightarrow$ Viral localization in hepatic tissue $\rightarrow$ Severe destruction of hepatocytes (liver cells) $\rightarrow$ Acute hepatic insufficiency $\rightarrow$ Death.

• Pathogenesis of RVF-Induced Abortion:

  • Vector bite in pregnant animal $\rightarrow$ Bloodstream entry $\rightarrow$ Viraemia $\rightarrow$ Transplacental migration into uterus $\rightarrow$ Infection of fetus $\rightarrow$ Acute placentitis $\rightarrow$ Severe impairment of fetal circulation $\rightarrow$ Fetal death $\rightarrow$ Abortion.

Clinical Signs and Epizootiology

• Young Animals (Lambs, Kids, Calves):

  • Incubation Period: Extremely short, approximately $12\text{ hours}$ in lambs.

  • Mortality Rate:

    • Lambs and Kids: Up to $90\%$

    • Calves: Up to $70\%$

  • Clinical Signs: Acute onset of high fever, severe dullness, anorexia, rapid collapse, coma, and sudden death within $24\text{ to }48\text{ hours}$.

• Adult Animals (Sheep, Goats, Cattle):

  • Incubation Period: $3\text{ to }4\text{ days}$.

  • Mortality Rate:

    • Adult Sheep: $20\%\text{ to }30\%$

    • Adult Cattle: $10\%$

  • Primary Clinical Sign: Mass abortion storms occurring at any stage of pregnancy.

  • Abortion Rate: Ranges from $40\%$ up to $100\%$. Aborted fetuses are typically autolyzed.

  • Secondary Signs: Nasal discharge, mucopurulent exudate, and bloody diarrhea in severe cases.

Clinical Presentation in Humans

• Incubation Period: $2\text{ to }6\text{ days}$.

• General Clinical Course:

  • RVF presents primarily as a severe influenza-like illness characterized by sudden onset of fever, myalgia, arthralgia, and headaches.

  • Full recovery typically occurs within $4\text{ to }7\text{ days}$.

  • Overall human mortality rate is approximately $1\%$

• Severe Complications:

  1. Encephalitis: Severe brain inflammation that is frequently fatal.

  2. Hemorrhagic Fever: Widespread petechial and ecchymotic hemorrhages, hematemesis, and melena.

  3. Blindness / Ocular Lesions: Primary or temporary loss of vision resulting from severe retinal hemorrhage and vasculitis.

Post-Mortem Pathological Lesions

• Primary Target Organ: Liver.

• Gross Pathological Changes:

  • Widespread focal to diffuse hepatic necrosis.

  • Presence of pinpoint petechial hemorrhages across the liver surface and parenchyma.

  • Mottled, pale discolored appearance with acute liver engorgement.

  • Gastrointestinal mucosal petechiae and blood-filled intestinal contents in animals showing hemorrhagic enteritis.

Diagnostic Protocols

Suspicion of Rift Valley Fever requires immediate laboratory verification due to its high zoonotic and economic significance.

• Diagnostic Criteria:

  1. Clinical Signs & Post-Mortem Findings: Presence of sudden death in young stock, mass abortion storms in adults, and extensive hepatic necrosis on post-mortem examination.

  2. Seasonal & Environmental Occurrence: Outbreaks strongly correlated with heavy rainfall periods, high humidity, and surge in vector mosquito populations.

  3. Virus Isolation & Identification: Direct isolation of the virus from acute blood samples, whole liver, spleen, or aborted fetal tissues.

  4. Polymerase Chain Reaction (PCR): Molecular detection of viral RNA for rapid identification.

  5. Animal Inoculation: Experimental inoculation in susceptible laboratory animals (e.g., mice).

  6. Serology: Enzyme-Linked Immunosorbent Assay (ELISA) and neutralization assays to detect specific IgM and IgG antibodies.

Differential Diagnosis, Prognosis, and Treatment

• Differential Diagnosis: Must be differentiated from other infectious diseases causing acute death and mass abortion in ruminants, particularly those presenting with high mortality over a short clinical course.

• Prognosis: Poor in newborn lambs, kids, and calves; guarded to grave for pregnant herds during active epizootics.

• Treatment: No specific antiviral therapy exists. Treatment is strictly symptomatic and supportive.

Prevention and Control Strategies

• Housing & Environmental Management:

  • Keep livestock inside insect-proof housing at night during peak mosquito feeding times.

• Vector Control:

  • Application of chemical insecticides and topical insect repellents.

  • Implementation of biological mosquito control methods to target breeding sites.

• Hygienic Measures & Biosafety:

  • Strict biohazard protocols during handling of aborted fetuses, placentas, body fluids, and necropsies to prevent aerosol and direct contact transmission to humans.

• Vaccination Regimens:

  • Inactivated (Killed) Vaccine:

    • Dose & Route: $1\,\text{mL}$ subcutaneously ($S/C$).

    • Duration of Immunity: Confers protection for $6\text{ months}$.

    • Safety: Safe for use in pregnant animals.

  • Live-Attenuated Vaccine:

    • Dose & Route: $1\,\text{mL}$ subcutaneously ($S/C$).

    • Duration of Immunity: Confers long-term protection for $3\text{ years}$.

    • Adverse Effects: Highly abortogenic in pregnant stock, causes temporary viraemia, and possesses teratogenic potential in fetuses.

  • MP-12 Vaccine: Mutagen-attenuated strain offering improved safety profiles.

  • Sub-unit Vaccines: Recombinant subunit formulations under development.

• Maternal Immunity & Vaccination Age:

  • Passive Maternal Immunity: Colostral antibodies protect young offspring for $2.5\text{ to }3\text{ months}$.

  • Vaccination Age: Initial vaccination of young stock is recommended between $2.2\text{ and }3\text{ months}$ of age.

Wesselsbron Disease

Wesselsbron disease is an infectious viral condition that closely parallels Rift Valley Fever across multiple clinical and epidemiological parameters.

• Epizootiological Similarities to RVF:

  • Matches RVF in host range, vector transmission pathways, clinical signs (abortions and neonatal mortalities), and gross post-mortem pathological lesions.

• Etiological Difference:

  • Caused by a member of the genus Flavivirus (Family Flaviviridae), whereas RVF is caused by a Phlebovirus (Family Bunyaviridae).

• Geographic Distribution:

  • Primarily identified and documented in South Africa.

• Control Measures:

  • Controlled through the strategic administration of inactivated and live-attenuated Wesselsbron virus vaccines.